Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 2;12(1):3469.
doi: 10.1038/s41598-022-07435-6.

Investigation of the relationship between ocular sarcoidosis and dry eye

Affiliations

Investigation of the relationship between ocular sarcoidosis and dry eye

Takanori Aoki et al. Sci Rep. .

Abstract

A relationship between ocular sarcoidosis (OcSar) and dry eye (DE) has previously been reported. Here we investigated the tear function in OcSar, and the other uveitis, Vogt-Koyanagi-Harada disease (VKH), to elucidate the association between OcSar and DE. This study involved 27 eyes of 27 female OcSar patients [mean age: 67.3 ± 13.5 (SD) years], 18 eyes of 18 female VKH patients (53.1 ± 14.1 years), and 17 eyes of 17 female healthy control subjects (59.7 ± 9.6 years). In all examined eyes, tear meniscus height (TMH, mm), fluorescein breakup time (FBUT, s), scoring of keratoconjunctival epithelial damage (ED), and the Schirmer 1 test (ST1, mm/5 min) were analyzed. In the OcSar patients, VKH patients, and control subjects, the respective TMH, FBUT, ED, and ST1 values (mean ± SD) were 0.26 ± 0.10, 0.24 ± 0.09, and 0.24 ± 0.08, 4.3 ± 2.5, 7.3 ± 2.9, and 6.3 ± 3.1, 1.1 ± 1.1, 0.7 ± 0.8, and 0.1 ± 0.3, and 12.9 ± 10.5, 21.5 ± 12.1, and 24.3 ± 10.5. Statistically, the ST1 values were significantly lower in the OcSar patients than in the VKH patients (P = 0.004) and control subjects (P = 0.001). ST1 findings revealed that the neural reflex arc and lacrimal gland system, which attenuate the vicious cycle between the tear film and ocular surface epithelium in DE, are significantly impaired in OcSar cases, thus indicating a possible association between OcSar and DE.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
(a) Comparison of tear meniscus height (TMH, mm) between the ocular sarcoidosis (OcSar) group (0.26 ± 0.10 mm), Vogt–Koyanagi–Harada disease (VKH) group (0.24 ± 0.09 mm), and normal control (NC) group (0.24 ± 0.08 mm) (all values are mean ± SD). No statistical difference was found. (b) Comparison of fluorescein breakup time (FBUT, seconds) between the OcSar group (4.3 ± 2.5 s), VKH group (7.3 ± 2.9 s) and OcSar group (6.3 ± 3.1 s) (all values are mean ± SD). Significant differences were found between the one of 3 groups [P = 0.002 (OcSar vs. VKH), P = 0.057 (OcSar vs. NC), and P = 0.527 (VKH vs. NC)]. (c) Comparison of keratoconjunctival epithelial damage (ED) between the OcSar group (1.1 ± 1.1), VKH group (0.7 ± 0.8), and NC group (0.1 ± 0.3) (all values are mean ± SD). There were significant differences between the two of 3 groups [P = 0.358 (OcSar vs. VKH), P = 0.001 (OcSar vs. NC), and P = 0.040 (VKH vs. NC)]. (d) Comparison of the Schirmer 1 test results (ST1, mm/5 min) between the OcSar group (12.9 ± 10.5 mm), VKH group (21.5 ± 12.1 mm), and NC group (24.3 ± 10.5 mm) (all values are mean ± SD). The ST1 values in the OcSar group were significantly lower than those in the VKH group and NC group [P = 0.004 (OcSar vs. VKH), P = 0.001 (OcSar vs. VKH)].

References

    1. Hunninghake GW, et al. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc. Diffuse Lung Dis. 1999;16:149–173. - PubMed
    1. Sawahata M, et al. Age-related and historical changes in the clinical characteristics of sarcoidosis in Japan. Respir. Med. 2015;109:272–278. doi: 10.1016/j.rmed.2014.12.012. - DOI - PubMed
    1. Morimoto T, et al. Epidemiology of sarcoidosis in Japan. Eur. Respir. J. 2008;31:372–379. doi: 10.1183/09031936.00075307. - DOI - PubMed
    1. Pasadhika S, Rosenbaum JT. Ocular sarcoidosis. Clin. Chest Med. 2015;36:669–683. doi: 10.1016/j.ccm.2015.08.009. - DOI - PMC - PubMed
    1. Yanardag H, Pamuk ON. Lacrimal gland involvement in sarcoidosis. The clinical features of 9 patients. Swiss Med. Wkly. 2003;133:388–391. - PubMed

Publication types